Multiple sclerosis(Panntherapi SAS)

N/A

Report date: 2025/09/24 17:58:01
NME

Base Information

Drug NameMultiple sclerosis(Panntherapi SAS)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPanntherapi
China Registration ClassN/A

Develop Information

Active CompaniesPanntherapi
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A